Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
08. October 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9594
Articles 1 - 20 / 191868
Treatment-Effect Heterogeneity and a Simple Framework for Estimating Survival Benefit Associated With Local Therapy in Nonmetastatic Advanced Prostate Cancer: A Multicenter KAMU-ON Cohort Study.
Int J Urol
Iwamoto H, Izumi K, Machioka K, Toriumi R, Shima T, Nozaki M, Hori T, Inaba T, Nakagawa R, Kamijima T, Kadomoto S, Makino T, Naito R, Yaegashi H, Shigehara K, Nohara T, Miyagi T, Seto C, Kadono Y, Mizokami A.
PMID: 42844150 [PubMed - indexed for MEDLINE]
Re: Benedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al. Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment. Eur Urol Focus. In press. http://dx.doi.org/10.1016/j.euf.2026.05.002.
Eur Urol Focus
Rodriguez-Sanchez L, Giannarini G, Gomez-Rivas J, EAU Oncology Section Prostate Cancer Working Group.
PMID: 42844119 [PubMed - as supplied by publisher]
Oncological Outcomes of Neoadjuvant Chemotherapy in High-Risk UTUC: A Multicenter Study.
Int J Urol
Saito S, Sazuka T, Washino S, Kaneko G, Nagamoto S, Nakamura Y, Nakayama A, Pae S, Ando K, Yamada Y, Imamura Y, Sakamoto S.
PMID: 42843987 [PubMed - indexed for MEDLINE]
Clinical utility of combining the C-reactive protein-to-albumin ratio and systemic immune-inflammation index for prognostic assessment in metastatic renal cell carcinoma.
PLoS One
Muramoto N, Nagata M, Hirano H, Shirakawa T, China T, Kawano H, Isotani S, Ide H, Honda H, Horie S.
PMID: 42842585 [PubMed - indexed for MEDLINE]
Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan.
Int J Clin Oncol
Habano E, Sato Y, Ogawa M, Watanabe K, Akiyama N, Chang H, Shijiki E, Nagai S, Kunita A, Ueki A, Kage H, Oda K.
PMID: 42842178 [PubMed - as supplied by publisher]
Kidney function changes following percutaneous cryoablation of renal tumors: A single-center cohort study.
Adv Clin Exp Med
Nowak , , Tomczak WA, Biesiadecki , Chorbi, Kruczek A, Gurwin A, Patrza, Karwacki J, Giudice FD, Chung BI, Ma, Szydelko T, Guzi, Krajewski W.
PMID: 42841607 [PubMed - as supplied by publisher]
Linear Accelerator-Based Stereotactic Body Radiotherapy of 36.25 Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single-Institution Cohort Study.
J Med Imaging Radiat Oncol
Katano A, Yamashita H.
PMID: 42841368 [PubMed - as supplied by publisher]
Isolated Prostatic Tuberculosis Coexisting with Benign Prostatic Hyperplasia: A Case Report.
Int Med Case Rep J
Modabber MH, Kamal MI, Sarwary MF, Bawarzai A, Sediqi M, Marofi M, Sadeqy L, Azizi A.
PMID: 42841063 [PubMed - indexed for MEDLINE]
Traditional Chinese medicine in non-muscle-invasive bladder cancer: a scoping review of syndrome characteristics and critical synthesis of pharmacological and mechanistic evidence.
Front Pharmacol
Zhang XZ, Xiang JA, Yang LC, Li YD, Zheng X, Qian J.
PMID: 42840653 [PubMed]
Impact of Cardio-cerebrovascular Diseases on Enzalutamide and Abiraterone Treatment in Castration-resistant Prostate Cancer.
JMA J
Kawai N, Izumi K, Yasui T, Shima T, Kato Y, Mita K, Okamura T, Inoue S, Tatarano S, Tanaka N, Kamiyama M, Chikazawa I, Hoshi S, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A.
PMID: 42840419 [PubMed]
Aromatic amine exposure and bladder cancer: a review of recent advances in epidemiology, pathogenesis, and prevention.
Front Cell Dev Biol
Li S, Zhang Y, Mao T, Wei J, Zhang W, Zhang J, Wei W.
PMID: 42840084 [PubMed]
Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis.
J Med Econ
Padula WV, Cohen BG, Steel P, Appukkuttan S, Kalayeh B, Rettig M.
PMID: 42839780 [PubMed - indexed for MEDLINE]
Optimizing photon counting detector CT reconstructions for automatic vessel tracing in prostate artery embolization.
J Appl Clin Med Phys
Froelich T, Linch FB, Thompson SM, Jundt MC, Collins JD, Ferrero A, Favazza CP.
PMID: 42839535 [PubMed - indexed for MEDLINE]
Combined radiological approach for characterization of solid renal masses: a proposed strategy for integrating the RENAL nephrometry score into the clear cell likelihood score.
BMC Med Imaging
Hekimsoy , Tan AA, Sars, Güler E.
PMID: 42839229 [PubMed - indexed for MEDLINE]
Association of molecular subtypes based on GATA3, KRT5, and P16 expression with clinicopathological features and prognosis in upper tract urothelial carcinoma.
World J Urol
Yang J, Yu W, Zhang S, Chen Q.
PMID: 42839075 [PubMed - indexed for MEDLINE]
Re: Targeted Prostate Cancer Screening in BRCA1 or BRCA2 Pathogenic Germline Variant Carriers Detects Clinically Relevant Disease: Five-year Results of the IMPACT Study.
Eur Urol
Greco F.
PMID: 42838800 [PubMed - as supplied by publisher]
Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE Trial.
Eur Urol
El-Taji O, Dutey-Magni P, Brown M, Murray M, Amos C, Gilbert D, Parmar M, Brown L, Sydes M, Attard G, James N, Clarke NW, Sachdeva A, STAMPEDE Collaborators.
PMID: 42838799 [PubMed - as supplied by publisher]
Adamantinoma-like Ewing sarcoma of the bladder.
BMJ Case Rep
Cronin C, Lokeshwar SD, Calagua C, Garman TS, Kates M, Aragon-Ching JB, Benyounes A, Smith AK.
PMID: 42838705 [PubMed - indexed for MEDLINE]
Superhydrophobic micro-structural substrate for renal cell carcinoma detection using LIBS-FTIR dual-spectra.
Anal Chim Acta
Chen W, Huang W, Li F, Guo L.
PMID: 42838663 [PubMed - indexed for MEDLINE]
Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA.
BMJ Open
Lichtman-Mikol S, Lang JM, Nagar H, Zuhour R, Chaung KV, Zaorsky NG, Roy S, Mendiratta PM, Shoag JE, Janopaul-Naylor JR, Khani F, Schaeffer EM, Kyriakopoulos CE, Barata P, Brown JR, Garcia JA, Barbieri CE, Sun Y, Choyke PL, Spratt DE, Jia AY.
PMID: 42838582 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 191868
Page 1 of 9594
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy